ATE359817T1 - Auf n-formyl methionyl peptide basierendem adjuvans für impfstoffe - Google Patents
Auf n-formyl methionyl peptide basierendem adjuvans für impfstoffeInfo
- Publication number
- ATE359817T1 ATE359817T1 AT99969285T AT99969285T ATE359817T1 AT E359817 T1 ATE359817 T1 AT E359817T1 AT 99969285 T AT99969285 T AT 99969285T AT 99969285 T AT99969285 T AT 99969285T AT E359817 T1 ATE359817 T1 AT E359817T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccines
- based adjuvant
- formyl methionyl
- methionyl peptide
- formyl
- Prior art date
Links
- -1 N-FORMYL METHIONYL Chemical class 0.000 title abstract 2
- 239000002671 adjuvant Substances 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title 1
- PRQROPMIIGLWRP-UHFFFAOYSA-N N-formyl-methionyl-leucyl-phenylalanin Chemical compound CSCCC(NC=O)C(=O)NC(CC(C)C)C(=O)NC(C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-UHFFFAOYSA-N 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000000568 immunological adjuvant Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
- Y10S977/917—Vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/918—Immunological
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/92—Detection of biochemical
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/216,702 US6017537A (en) | 1998-12-18 | 1998-12-18 | Formyl methionyl peptide vaccine adjuvant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE359817T1 true ATE359817T1 (de) | 2007-05-15 |
Family
ID=22808169
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99969285T ATE359817T1 (de) | 1998-12-18 | 1999-12-17 | Auf n-formyl methionyl peptide basierendem adjuvans für impfstoffe |
| AT07007842T ATE496630T1 (de) | 1998-12-18 | 1999-12-17 | Immunologische zusammensetzung und impfstoffe, die einen auf n-formyl-methionyl peptide bestehenden adjuvans enthalten |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07007842T ATE496630T1 (de) | 1998-12-18 | 1999-12-17 | Immunologische zusammensetzung und impfstoffe, die einen auf n-formyl-methionyl peptide bestehenden adjuvans enthalten |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6017537A (de) |
| EP (2) | EP1140166B1 (de) |
| JP (1) | JP2002532436A (de) |
| AT (2) | ATE359817T1 (de) |
| AU (1) | AU773697B2 (de) |
| CA (2) | CA2718376A1 (de) |
| CY (2) | CY1106635T1 (de) |
| DE (2) | DE69935866T2 (de) |
| DK (2) | DK1140166T3 (de) |
| ES (2) | ES2284285T3 (de) |
| NZ (1) | NZ510544A (de) |
| PT (2) | PT1800692E (de) |
| SI (2) | SI1800692T1 (de) |
| WO (1) | WO2000035482A2 (de) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010018579A1 (en) | 1998-12-18 | 2001-08-30 | Walter Klemp | Disposable absorbent garment having stretchable side waist regions |
| GB9924351D0 (en) | 1999-10-14 | 1999-12-15 | Brennan Frank | Immunomodulation methods and compositions |
| AU2001264892B2 (en) * | 2000-05-23 | 2006-03-16 | Mowycal Lending, Llc | Modulaton of alpha-6 integrin-mediated responses |
| CA2950109C (en) * | 2000-10-27 | 2019-02-19 | John W. Hadden | Vaccine immunotherapy for immune suppressed patients |
| US20070025958A1 (en) * | 2000-10-27 | 2007-02-01 | Hadden John W | Vaccine immunotherapy |
| JP2006516883A (ja) | 2002-09-19 | 2006-07-13 | アメリカ合衆国 | P.アリアシポリペプチド、ユウガイサシチョウバエポリペプチド、および使用法 |
| DE60327366D1 (de) | 2002-10-29 | 2009-06-04 | Fundacao Oswaldo Cruz | Lutzomyia longipalpis-polypeptide und verwendungsverfahren |
| US7270949B2 (en) * | 2003-01-07 | 2007-09-18 | Neuromed Pharmaceuticals Ltd. | Fluorescence based T-type channel assay |
| US7425700B2 (en) * | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
| EP1734991A4 (de) * | 2004-04-14 | 2012-10-24 | Avirid Inc | Zusammensetzungen mit modifizierten, auf virale nukleinsäuren gerichteten nukleasen und verfahren zur verwendung für prävention und behandlung von viruserkrankungen |
| US7998733B2 (en) | 2004-10-05 | 2011-08-16 | Merial Limited | Chimeric vectors |
| AU2006210392A1 (en) * | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune response modifiers |
| US7887522B2 (en) | 2005-03-18 | 2011-02-15 | The Procter And Gamble Company | Pull-on wearable article with informational image |
| US7806880B2 (en) * | 2005-03-18 | 2010-10-05 | The Procter & Gamble Company | Pull-on wearable article with informational image |
| US20060264858A1 (en) * | 2005-05-20 | 2006-11-23 | Roe Donald C | Multi-functional training garment |
| AU2006279612B2 (en) | 2005-08-15 | 2013-03-21 | Altimmune Inc. | Immunization of avians by administration of non-replicating vectored vaccines |
| US7432413B2 (en) | 2005-12-16 | 2008-10-07 | The Procter And Gamble Company | Disposable absorbent article having side panels with structurally, functionally and visually different regions |
| US8664467B2 (en) | 2006-03-31 | 2014-03-04 | The Procter & Gamble Company | Absorbent articles with feedback signal upon urination |
| EP2035041B1 (de) * | 2006-06-30 | 2020-01-08 | Syntab Therapeutics GmbH | Konjugate für die immanente immuntherapie bei krebs |
| US7896858B2 (en) * | 2006-12-04 | 2011-03-01 | The Procter & Gamble Company | Absorbent articles comprising graphics |
| WO2009137577A2 (en) | 2008-05-08 | 2009-11-12 | Merial Limited | Leishmania vaccine using sand fly salivary immunogen |
| US9400873B2 (en) | 2011-12-21 | 2016-07-26 | Deka Products Limited Partnership | System, method, and apparatus for dispensing oral medications |
| WO2011119920A2 (en) | 2010-03-25 | 2011-09-29 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
| ES2667425T3 (es) | 2011-06-10 | 2018-05-10 | Oregon Health & Science University | Glucoproteínas y vectores recombinantes de CMV |
| RS58289B1 (sr) | 2011-07-20 | 2019-03-29 | Merial Ltd | Rekombinantna vakcina protiv virusa mačje leukemije koja sadrži optimizovani gen omotača virusa mačje leukemije |
| CA2844927C (en) | 2011-08-12 | 2017-10-31 | Merial Limited | Vacuum-assisted preservation of biological products, in particular of vaccines |
| AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
| EP2586461A1 (de) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Von einem eingehüllten Virus abgeleitete Virenpartikel |
| US10563681B2 (en) | 2011-12-21 | 2020-02-18 | Deka Products Limited Partnership | System, method, and apparatus for clamping |
| NZ700470A (en) | 2012-03-20 | 2016-04-29 | Merial Inc | Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof |
| WO2013170433A1 (en) | 2012-05-15 | 2013-11-21 | The Procter & Gamble Company | Absorbent article having characteristic waist end |
| EP2679596B1 (de) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 Env-proteinvariante |
| US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
| EP2873423B1 (de) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
| WO2015175672A1 (en) | 2014-05-14 | 2015-11-19 | Merial, Inc. | Methods for freeze-drying and rehydrating biologics |
| US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| EP3072901A1 (de) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
| KR102726776B1 (ko) * | 2021-07-09 | 2024-11-06 | 포항공과대학교 산학협력단 | 포밀 메티오닌 특이 항체 제조를 위한 신규한 항원 펩타이드 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL89118A0 (en) * | 1988-02-03 | 1989-08-15 | Microgenesys Inc | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 |
| US5861158A (en) * | 1993-11-17 | 1999-01-19 | The United States Of America As Represented By The Deptartment Of Health And Human Services | Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor |
-
1998
- 1998-12-18 US US09/216,702 patent/US6017537A/en not_active Expired - Lifetime
-
1999
- 1999-12-17 DE DE69935866T patent/DE69935866T2/de not_active Expired - Lifetime
- 1999-12-17 JP JP2000587801A patent/JP2002532436A/ja active Pending
- 1999-12-17 DK DK99969285T patent/DK1140166T3/da active
- 1999-12-17 NZ NZ510544A patent/NZ510544A/xx not_active IP Right Cessation
- 1999-12-17 CA CA2718376A patent/CA2718376A1/en not_active Abandoned
- 1999-12-17 AU AU28451/00A patent/AU773697B2/en not_active Ceased
- 1999-12-17 AT AT99969285T patent/ATE359817T1/de active
- 1999-12-17 EP EP99969285A patent/EP1140166B1/de not_active Expired - Lifetime
- 1999-12-17 DK DK07007842.3T patent/DK1800692T3/da active
- 1999-12-17 WO PCT/US1999/030188 patent/WO2000035482A2/en not_active Ceased
- 1999-12-17 SI SI9931051T patent/SI1800692T1/sl unknown
- 1999-12-17 DE DE69943170T patent/DE69943170D1/de not_active Expired - Lifetime
- 1999-12-17 EP EP07007842A patent/EP1800692B1/de not_active Expired - Lifetime
- 1999-12-17 PT PT07007842T patent/PT1800692E/pt unknown
- 1999-12-17 ES ES99969285T patent/ES2284285T3/es not_active Expired - Lifetime
- 1999-12-17 ES ES07007842T patent/ES2358540T3/es not_active Expired - Lifetime
- 1999-12-17 CA CA2342609A patent/CA2342609C/en not_active Expired - Fee Related
- 1999-12-17 PT PT99969285T patent/PT1140166E/pt unknown
- 1999-12-17 AT AT07007842T patent/ATE496630T1/de active
- 1999-12-17 SI SI9930961T patent/SI1140166T1/sl unknown
-
2007
- 2007-06-04 CY CY20071100731T patent/CY1106635T1/el unknown
-
2011
- 2011-04-05 CY CY20111100355T patent/CY1111372T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69935866D1 (de) | 2007-05-31 |
| HK1110769A1 (en) | 2008-07-25 |
| CA2342609A1 (en) | 2000-06-22 |
| NZ510544A (en) | 2003-04-29 |
| US6017537A (en) | 2000-01-25 |
| PT1140166E (pt) | 2007-06-27 |
| WO2000035482A3 (en) | 2000-10-26 |
| EP1800692A1 (de) | 2007-06-27 |
| AU773697B2 (en) | 2004-06-03 |
| ES2358540T3 (es) | 2011-05-11 |
| CY1106635T1 (el) | 2012-01-25 |
| PT1800692E (pt) | 2011-03-31 |
| AU2845100A (en) | 2000-07-03 |
| EP1140166A2 (de) | 2001-10-10 |
| ATE496630T1 (de) | 2011-02-15 |
| EP1800692B1 (de) | 2011-01-26 |
| CY1111372T1 (el) | 2015-08-05 |
| DK1800692T3 (da) | 2011-03-28 |
| EP1140166B1 (de) | 2007-04-18 |
| DE69935866T2 (de) | 2008-01-10 |
| JP2002532436A (ja) | 2002-10-02 |
| SI1140166T1 (sl) | 2007-08-31 |
| DK1140166T3 (da) | 2007-07-02 |
| WO2000035482A2 (en) | 2000-06-22 |
| DE69943170D1 (de) | 2011-03-10 |
| ES2284285T3 (es) | 2007-11-01 |
| CA2718376A1 (en) | 2000-06-22 |
| SI1800692T1 (sl) | 2011-05-31 |
| CA2342609C (en) | 2010-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69935866D1 (de) | Auf N-Formyl Methionyl Peptide basierendem Adjuvans für Impfstoffe | |
| EP0667786A4 (de) | Retro-, inverso-, und retro-inverso synthetische peptidanaloge. | |
| IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
| BG98523A (en) | Hla-limited cytotoxic t-lymphocytic (ctl) epitopes of the virus of hepatite b | |
| ATE320493T1 (de) | Modifizierung des hepatitis b kernantigens | |
| DK0608261T3 (da) | Sammensætninger med immunreaktivt hepatitis C virus polypeptid | |
| DK0528859T3 (da) | Oral vaccine, som omfatter antigen knyttet til overfladen af røde blodlegemer | |
| ES2075440T3 (es) | Vacuna contra la hepatitis b. | |
| DK1362109T3 (da) | Rekombinante oligomere protein-komplekser med foröget immunogent potentiale | |
| DK1033995T3 (da) | Hele eller sprængte insektceller som adjuvans for antigener | |
| DK47286A (da) | Hundeparvovirus-vacciner | |
| ATE141328T1 (de) | Rekombinante vakzine gegen coccidiose | |
| DE60036692D1 (de) | Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion | |
| EA200100395A1 (ru) | Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием | |
| NO924271L (no) | Vaksiner med forbedret immunogenisitet | |
| WO2004022092A3 (en) | Flagellin peptides as adjuvants for vaccines | |
| CA2516661A1 (en) | M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever | |
| UA42741C2 (uk) | Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти) | |
| ATE312923T1 (de) | Moraxella catarrhalis basb034 polypeptide und verwendungen davon | |
| MX9102647A (es) | Nueva proteina capaz de inducir una respuesta inmunoprotectora contra la infeccion causada por toxoplasma gondii y para clonar y expresar un gen que codifica a la proteina. | |
| ATE431745T1 (de) | Ltb4 als adjuvans für impfstoffe | |
| DE69130675D1 (de) | Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum | |
| WO2002004497A3 (en) | Multiple antigenic peptides immunogenic against streptococcus pneumoniae | |
| PL442478A1 (pl) | Kompozycja szczepionki do zastosowania w profilaktyce chorób zakaźnych | |
| NZ335929A (en) | Use of a recombinant polypeptide having a glycosyl-phosphatidylinositol anchor for inducing an immune response |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1140166 Country of ref document: EP |